Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Vertex Pharmaceuticals Incorporated Company Profile (NASDAQ:VRTX)

Consensus Ratings for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) (?)
Ratings Breakdown: 5 Hold Rating(s), 11 Buy Rating(s)
Consensus Rating:Buy (Score: 2.69)
Consensus Price Target: $122.71 (8.94% upside)

Current Analysts' Coverage Summary for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/29/2014JMP SecuritiesReiterated RatingMarket Outperform$115.00 -> $133.00ViewTweet This Rating  Share This Rating on StockTwits
10/29/2014RBC CapitalBoost Price TargetOutperform$120.00 -> $130.00ViewTweet This Rating  Share This Rating on StockTwits
10/27/2014ZacksReiterated RatingNeutral -> Neutral$115.00ViewTweet This Rating  Share This Rating on StockTwits
10/13/2014Wells Fargo & Co.UpgradeNeutral -> Outperform$129.00 -> $125.00ViewTweet This Rating  Share This Rating on StockTwits
10/13/2014Piper JaffrayUpgradeNeutral -> Overweight$87.50 -> $125.00ViewTweet This Rating  Share This Rating on StockTwits
10/10/2014Deutsche BankReiterated RatingBuy$127.00ViewTweet This Rating  Share This Rating on StockTwits
10/10/2014Maxim GroupBoost Price TargetBuy$109.00 -> $117.00ViewTweet This Rating  Share This Rating on StockTwits
10/2/2014GuggenheimInitiated CoverageBuy$147.00ViewTweet This Rating  Share This Rating on StockTwits
9/5/2014Goldman SachsUpgradeNeutral -> Buy$109.00 -> $131.00ViewTweet This Rating  Share This Rating on StockTwits
7/9/2014TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
7/7/2014OppenheimerDowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
6/25/2014Citigroup Inc.Reiterated RatingBuy$103.00 -> $136.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2014Sanford C. BernsteinBoost Price Target$65.00 -> $107.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2014Leerink SwannBoost Price TargetOutperform$100.00 -> $125.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2014HC WainrightDowngradeBuy -> Neutral$105.00 -> $85.00ViewTweet This Rating  Share This Rating on StockTwits
6/24/2014Needham & Company LLCBoost Price TargetPositive -> Buy$95.00 -> $115.00ViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
10/30/2013Credit SuisseLower Price TargetNeutral$80.00 -> $78.00ViewTweet This Rating  Share This Rating on StockTwits
10/30/2013Summer StreetDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
10/29/2013Cowen and CompanyLower Price TargetNeutral$87.94 -> $80.00ViewTweet This Rating  Share This Rating on StockTwits
10/16/2013BarclaysLower Price TargetOverweight$95.00 -> $92.00ViewTweet This Rating  Share This Rating on StockTwits
7/23/2013William BlairBoost Price Target$83.00 -> $94.00ViewTweet This Rating  Share This Rating on StockTwits
4/22/2013S&P Equity ResearchBoost Price TargetBuy$60.00 -> $100.00ViewTweet This Rating  Share This Rating on StockTwits
4/19/2013Robert W. BairdBoost Price TargetOutperform$53.00 -> $88.00ViewTweet This Rating  Share This Rating on StockTwits
4/19/2013Chardan CapitalBoost Price TargetBuy$80.00 -> $105.00ViewTweet This Rating  Share This Rating on StockTwits
4/19/2013Canaccord GenuityUpgradeHold -> Buy$55.00 -> $96.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2013JPMorgan Chase & Co.Reiterated RatingOverweight$82.00 -> $86.00ViewTweet This Rating  Share This Rating on StockTwits
1/15/2013Lazard LtdDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Janney Montgomery ScottInitiated CoverageBuy$54.00ViewTweet This Rating  Share This Rating on StockTwits
11/28/2012ArgusDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
11/2/2012Brean CapitalReiterated RatingBuy$69.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/31/2012 forward)
Discuss Vertex Pharmaceuticals Incorporated